Article PDF
Avoid common mistakes on your manuscript.
References
Cameron IT, Baird DT. The use of 16, 16 dimethyl trans delta 2 prostaglandin E1 melhyl ester (gemeprost) vaginal pessaries. British Journal of Obstetrics and Gynaecology 91: 1136–40, 1984
Cameron IT, Baird DT. Early pregnancy termination: a comparison between vacuum aspiration and medical termination using prostaglandin (16.16 dimethyl trans delta 2 prostaglandin E1 methyl ester) or the antiprogestin RU486. British Journal of Obstetrics and Gynaecology 95: 271–276, 1988
Cameron IT, Michie AF, Baird DT. Therapeutic abortion in early pregnacy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost). Contraception 34: 459–468, 1986
Coelho HLL, Teixeira AC, Santos AP, Forte EB, Morais SM, et al. Misoprostol and illegal abortion in Fortalcza, Brazil. Lancet 341: 1261–1263, 1993
Costa SN, Vessey MP. Misoprostol and illegal abortion in Rio dc Janeiro, Brazil. Lancet 341: 1258–1261, 1993
Couzinet B, Le Strat N, Ulmann A, Baulieu EE, Sehaison G. Termination of early pregnancy by the progesterone antagonist RU4S6 (mifepristone). New England Journal of Medicine 315: 1565–1570, 1986
Dorozynski A. Tempest in a pill box. British Medical Journal 297: 1291, 1988
Dorozynski A. The American trials of mifepristone. British Medical Journal 302: 487, 1991
Dorrell S. House of Commons official report (Hansard, UK), July 23; pp. 195 (col 5), 1991
Green K, Bygdecnan M, Bremme K. Interruption of early first trimester pregnancy by single vaginal administration of 15 methyl prostaglandin F2 alpha-methyl ester. Contraception 18: 551–560, 1978
Grimes DA, Mishell DK, Shoupe D, Lacarra M. Early abortion with a single dose of the antiprogestin RU486. American Journal of Obstetrics and Gynaecology 158: 1307–1312, 1988
Heard M. Guillebaud J. Medical abortion. British Medical Journal 304: 195–196, 1992
Henrion R. RU486 abortions. Nature 338: 110, 1989
Henshaw RC, Templeton AA, Naji SA, Russell IT. Medical abortion. British Medical Journal 304: 914, 1992
Henshaw SK. Induced abortion: a worldwide perspective. Family Planning Perspectives 18: 250–254, 1986
Kidd GM. Medical abortion. British Medical Journal 304: 1380, 1992
Leary W. Maker of abortion pills reaches licensing pact with U/S group. New York Times, A18, April 21, 1993
Mangla B. Mifepristone opposed. Lancet 342: 110, 1993
Mishell DR, Shoupe D, Brenner PF, Lacarra M, Horenstein J, et al. Termination of early gestation with the anti-progesttn steroid RU486: medium versus low dose. Contraception 35: 307–321, 1987
Munday D, Francombe C, Savage W. 21 years of legal abortion. British Medical Journal 298: 1231–1234, 1989
Office of Population Censuses and Surveys. Abortion statistics. HMSO, London, 1993
Rosen A, Nystedt L, Bygcfcman M, et al. Acceptability of a nonsurgical method to terminate very early pregnancy in comparison to vacuum aspiration. Contraception 19: 107–117, 1979
Roussel Laboratories. Mifepristone tablets data sheet. Roussel Laboratories, Uxbridge, Middlesex, 1991
Silvestre L, Dubois C, Renault M, Rezvani Y, Baulieu EE, et al. Voluntary interruption of pregnancy with mifepristone (RU486) and a prostaglandin analogue: a large scale French experience. New England Journal of Medicine 322: 645–648, 1990
Smith SK, Baird DT. The use of 16, 16 dimethyl trans delta 2 prostaglandin E1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy: a comparative study. British Journal of Obstetrics and Gynaecology 87: 712–717, 1980
Tang GWK, Lau OWK, Yip P. Further acceptability evaluation of RLI-486 and ONO-802 as abortifacient agents in a Chinese population. Contraception 48: 267–276, 1993
Thong KJ, Baird DT. Induction of abortion with mifepristone and misoprostol in early pregnancy. British Journal of Obstetrics and Gynaecology 99: 1004–1007, 1992a
Thong KJ, Baird DT. Induction of second trimester abortion with mifepristone and gemeprost. British Journal of Obstetrics and Gynaecology 100: 758–761, 1992b
Toppozada MK. Prostaglandins in mid trimester abortion. Prostaglandin Perspectives 2(Part 4): 1–3, 1986
UK Multicentre Trial. The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnaney. British Journal of Obstetrics and Gynaecology 97: 480–486, 1990
Urquhart DR, Teittpleton AA. Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion. British Journal of Obstetrics and Gynaecology 98: 396–399, 1991
WHO Task Force. Termination of pregnancy with reduced doses of mifepristone. British Medical Journal 307: 532–537, 1993
Wood EV. Antihormones in obstetrics and gynaecology: ethical and social issues. Clinical Obstetrics and Gynaecology 2: 541–544, 1988
World Health Organisation. Induced abortion. Technical report series No. 623, WHO, Geneva, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Macrow, P.J. Political, Economic and Ethical Aspects of Use of Medical Abortifacients. Pharmacoeconomics 5, 269–273 (1994). https://doi.org/10.2165/00019053-199405040-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199405040-00001